(Q46820067)
Statements
Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up (English)
Haemophilus influenzae
1 reference
H R Shinefield
1 November 1995